Novel Non-Invasive Diagnosis of Bladder Cancer in Urine Based on Multifunctional Nanoparticles.

Novel Non-Invasive Diagnosis of Bladder Cancer in Urine Based on Multifunctional Nanoparticles.
复制标题

DOI:
10.3389/fcell.2021.813420
复制
发表时间:
2021
影响因子:
5.5
通讯作者:
Xu C
Xu C
中科院分区:
生物学2区
文献类型:
--
作者:
Xu J;Zeng S;Li J;Gao L;Le W;Huang X;Wang G;Chen B;Zhang Z;Xu C

文献摘要

参考文献

被引文献

相似文献

目的:肿瘤细胞由于糖酵解增加而具有永久的表面负电荷,多功能纳米探针(Fe3O4@SiO_2,mNPs)可以通过相反的表面电荷附着在肿瘤细胞上。因此,我们评估了MNPs与尿液混合是否可以提高尿液细胞学检查(UCT)的敏感性。方法:我们开发了一种新的UCT方法,将尿液和mNPs(纳米细胞学)混合在一起,在UCT过程中采集更多的肿瘤细胞。同样的尿液样本被平均分成纳米细胞学和UCT检测,并由细胞病理学家以盲法进行评估。确定了UCT、纳米细胞学以及两者结合(Nano-UCT)检测膀胱癌的准确性。结果:前瞻性采集了长海医院2020年6月至2021年2月102例膀胱癌患者和49例非肿瘤患者的尿样。纳米细胞学检测的总体敏感性显著高于UCT检测(82.4%vs.59.8%,p<.01)。对于低级别和高级别肿瘤,纳米细胞学和UCT的敏感度分别为79.1%和39.5%(p<.01)和84.7%和74.6%(p=0.25)。纳米细胞学的特异性略低于UCT(89.8%vs.100%,p=.022),这主要是由严重的尿路感染引起的。此外,Nano-UCT对所有患者的敏感度为90.2%,对低、高级别肿瘤的敏感度分别为83.7%和94.9%。结论:纳米细胞学检测膀胱癌的敏感性明显高于UCT。它为临床诊断膀胱癌提供了一种很有前途的工具。
Objectives: Tumor cells were reported to have perpetual negative surface charges due to elevated glycolysis, and multifunctional nanoprobes (Fe3O4@SiO2, mNPs) could attach onto tumor cells via opposite surface charges. We thus evaluated whether mixing mNPs with urine could improve the sensitivity of urine cytology test (UCT). Methods: We developed a novel UCT method by mixing urine with mNPs (Nano-cytology) to harvest more tumor cells during UCT procedures. The same voided urine sample was divided equally for the Nano-cytology and UCT assay, and evaluated by cytopathologists in a blinded way. The accuracy of UCT, Nano-cytology, and the combination of the two approaches (Nano-UCT) for detecting bladder cancer were determined. Results: Urine samples were prospectively collected from 102 bladder cancer patients and 49 non-cancer participants from June 2020 to February 2021 in Changhai Hospital. Overall sensitivity of the Nano-cytology assay was significantly higher than that of the UCT assay (82.4 vs. 59.8%, p < .01). Sensitivity for low- and high-grade tumors was 79.1% and 39.5% (p < .01) and 84.7% and 74.6% (p = .25) for Nano-cytology and UCT, respectively. Specificity of Nano-cytology was slightly lower than that of UCT (89.8% vs. 100%, p = .022), which is mainly caused by severe urinary tract infection. In addition, Nano-UCT showed increased sensitivity with 90.2% for overall patients, and 83.7% and 94.9% for low- and high-grade tumor, respectively. Conclusion: The Nano-cytology assay had a significantly improved sensitivity compared with UCT for detecting bladder cancer patients. It represents a promising tool for diagnosis of bladder cancer in clinical practice.
DOI: 10.1001/jama.293.7.810
发表时间: 2005-02-16
影响因子: 120.7
作者:
Grossman, HB;Messing, E;Shen, Y
通讯作者: Shen, Y
DOI: 10.1016/j.clinbiochem.2013.10.022
发表时间: 2014-01-01
影响因子: 2.8
作者:
Eissa, Sanaa;Shawky, Sherif M.;Azzazy, Hassan M. E.
通讯作者: Azzazy, Hassan M. E.
DOI: 10.1007/s11626-013-9651-z
发表时间: 2013-10-01
影响因子: 2.1
作者:
Xu, Chuanliang;Xu, Weidong;Sun, Yinghao
通讯作者: Sun, Yinghao
DOI: 10.2217/nnm.14.212
发表时间: 2015
期刊: Nanomedicine (London, England)
影响因子: --
作者:
Tomlinson B;Lin TY;Dall'Era M;Pan CX
通讯作者: Pan CX
DOI: 10.3390/ijms21186542
发表时间: 2020-09-08
影响因子: 5.6
作者:
Mancini M;Righetto M;Zumerle S;Montopoli M;Zattoni F
通讯作者: Zattoni F